Literature DB >> 17403877

Disruption of interleukin-27 signaling results in impaired gamma interferon production but does not significantly affect immunopathology in murine schistosome infection.

Mara G Shainheit1, Rosita Saraceno, Lindsey E Bazzone, Laura I Rutitzky, Miguel J Stadecker.   

Abstract

In schistosomiasis mansoni, parasite eggs cause hepatointestinal granulomatous inflammation and fibrosis mediated by CD4 T cells specific for egg antigens. The severity of disease varies extensively in humans and among mouse strains. Marked disease exacerbation induced in typically low-pathology C57BL/6 mice by immunization with schistosome egg antigens (SEA) in complete Freund's adjuvant (SEA/CFA) correlates with elevated production of the proinflammatory cytokines gamma interferon (IFN-gamma) and interleukin-17 (IL-17), which are regulated by IL-12 and IL-23, respectively. Here we examined the effect on the schistosome infection of a third member of the IL-12 family of heterodimeric cytokines, IL-27, using SEA/CFA-immunized and unimmunized mice deficient in the IL-27 receptor chain WSX-1 (WSX-1(-/-)). SEA-stimulated bulk mesenteric lymph node cells or CD4 T cells from 7-week-infected WSX-1(-/-) mice produced significantly less IFN-gamma than did those from C57BL/6 mice, even though there was no difference between these mice in exacerbated hepatic egg-induced granulomatous inflammation or in the levels of IL-17 induced by immunization with SEA/CFA. A fraction of the cells in the granulomas stained positive for IL-27, but there were no significant differences between WSX-1(-/-) and BL/6 mice, nor were there differences in the number of CD4 T cells and eosinophils. A 24-week chronic infection resulted in markedly reduced levels of proinflammatory cytokines, including IFN-gamma, in WSX-1(-/-) mice, but again the magnitude of immunopathology was not significantly different between the two groups. These findings indicate that despite the impaired IFN-gamma production, IL-27 signaling has no significant effect on either the magnitude of egg-induced immunopathology or on its closest in vitro correlate, IL-17.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403877      PMCID: PMC1932859          DOI: 10.1128/IAI.01053-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  The immunobiology of schistosomiasis.

Authors:  Edward J Pearce; Andrew S MacDonald
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

2.  IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni.

Authors:  Clare H Sadler; Laura I Rutitzky; Miguel J Stadecker; R Alan Wilson
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

3.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

4.  Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent.

Authors:  E A Patton; L R Brunet; A C La Flamme; J Pedras-Vasconcelos; M Kopf; E J Pearce
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation.

Authors:  H J Hernandez; A H Sharpe; M J Stadecker
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

6.  WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection.

Authors:  H Yoshida; S Hamano; G Senaldi; T Covey; R Faggioni; S Mu; M Xia; A C Wakeham; H Nishina; J Potter; C J Saris; T W Mak
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

7.  Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction.

Authors:  Andrew S MacDonald; Elisabeth A Patton; Anne C La Flamme; Maria I Araujo; Clive R Huxtable; Beverley Bauman; Edward J Pearce
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection.

Authors:  L I Rutitzky; H J Hernandez; M J Stadecker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 9.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

View more
  11 in total

1.  Immunoprotection of recombinant Eg.myophilin against Echinococcus granulosus infection in sheep.

Authors:  Mingxing Zhu; Fu Gao; Zihua Li; Xiuqing Wang; Hao Wang; Zhisheng Wang; Jiaqing Zhao; Wei Zhao
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

2.  Modulation of CD4+ and CD8+ T Cell Function and Cytokine Responses in Strongyloides stercoralis Infection by Interleukin-27 (IL-27) and IL-37.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

3.  Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice.

Authors:  Mingxing Zhu; Xiuqing Wang; Hao Wang; Zhisheng Wang; Jiaqing Zhao; Yana Wang; Wei Zhao
Journal:  Exp Ther Med       Date:  2015-06-18       Impact factor: 2.447

Review 4.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

5.  Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology.

Authors:  Mara G Shainheit; Patrick M Smith; Lindsey E Bazzone; Andrew C Wang; Laura I Rutitzky; Miguel J Stadecker
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.

Authors:  Charles F Anderson; Jason S Stumhofer; Christopher A Hunter; David Sacks
Journal:  J Immunol       Date:  2009-09-11       Impact factor: 5.422

7.  Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.

Authors:  Christian J Lechner; Karl Komander; Jana Hegewald; Xiangsheng Huang; Richard G Gantin; Peter T Soboslay; Abram Agossou; Meba Banla; Carsten Köhler
Journal:  Immun Ageing       Date:  2013-07-15       Impact factor: 6.400

8.  Systemic Cytokine and Chemokine Profiles in Individuals With Schistosoma mansoni Infection and Low Parasite Burden.

Authors:  Vanessa N Castro; Jailza L Rodrigues; Diogo T Cardoso; Samira D Resende; Fernanda C Magalhães; Dayane C Souza; Maira H Requeijo; Deborah Negrão-Corrêa; Stefan M Geiger
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

9.  Epigenetic and parasitological parameters are modulated in EBi3-/- mice infected with Schistosoma mansoni.

Authors:  Ester Alves Mota; Andressa Barban do Patrocínio; Vanderlei Rodrigues; João Santana da Silva; Vanessa Carregaro Pereira; Renata Guerra-Sá
Journal:  PLoS Negl Trop Dis       Date:  2020-02-20

10.  Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans.

Authors:  Guilherme Silva Miranda; Samira Diniz Resende; Diogo Tavares Cardoso; Genil Mororó Araújo Camelo; Jeferson Kelvin Alves Oliveira Silva; Vanessa Normandio de Castro; Stefan Michael Geiger; Mariângela Carneiro; Deborah Negrão-Corrêa
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.